The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Pyoderma


High impact information on Pyoderma


Chemical compound and disease context of Pyoderma


Biological context of Pyoderma


Anatomical context of Pyoderma


Gene context of Pyoderma

  • We present here the biological content of the Infevers database, including the introduction of two new entries: Crohn/Blau and Pyogenic sterile arthritis, pyoderma gangrenosum and acne (PAPA syndrome) [21].
  • A novel role for pyrin has been proposed by Shoham et al., who studied patients with an autosomal dominant disease called pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome [22].
  • Treatment of pyoderma gangrenosum with etanercept [23].
  • Pyoderma Gangrenosum and rheumatoid arthritis [24].
  • Fatal pyoderma gangrenosum in association with C7 deficiency [25].

Analytical, diagnostic and therapeutic context of Pyoderma


  1. 'Sticky' neutrophils, pathergic arthritis, and response to heparin in pyoderma gangrenosum complicating ulcerative colitis. Dwarakanath, A.D., Yu, L.G., Brookes, C., Pryce, D., Rhodes, J.M. Gut (1995) [Pubmed]
  2. IgA-associated inhibition of polymorphonuclear leukocyte chemotaxis in neutrophilic dermatoses. Schröder, J.M., Szperalski, B., Koh, C.J., Christophers, E. J. Invest. Dermatol. (1981) [Pubmed]
  3. Thalidomide increases human keratinocyte migration and proliferation. Nasca, M.R., O'Toole, E.A., Palicharla, P., West, D.P., Woodley, D.T. J. Invest. Dermatol. (1999) [Pubmed]
  4. Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease. Friedman, S., Marion, J.F., Scherl, E., Rubin, P.H., Present, D.H. Inflamm. Bowel Dis. (2001) [Pubmed]
  5. Pyoderma gangrenosum associated with ulcerative colitis: treatment with disodium cromoglycate. Cave, D.R., Burakoff, R. Am. J. Gastroenterol. (1987) [Pubmed]
  6. Suppression of the antistreptolysin O response by cholesterol and by lipid extracts of rabbit skin. Kaplan, E.L., Wannamaker, L.W. J. Exp. Med. (1976) [Pubmed]
  7. Mycophenolate mofetil and cyclosporin treatment for recalcitrant pyoderma gangrenosum. Hohenleutner, U., Mohr, V.D., Michel, S., Landthaler, M. Lancet (1997) [Pubmed]
  8. Nicotine for pyoderma gangrenosum. Kanekura, T., Usuki, K., Kanzaki, T. Lancet (1995) [Pubmed]
  9. Tacrolimus to treat pyoderma gangrenosum resistant to cyclosporine. D'Incà, R., Fagiuoli, S., Sturniolo, G.C. Ann. Intern. Med. (1998) [Pubmed]
  10. Diphtheria among alcoholic urban adults. A decade of experience in Seattle. Harnisch, J.P., Tronca, E., Nolan, C.M., Turck, M., Holmes, K.K. Ann. Intern. Med. (1989) [Pubmed]
  11. Pyoderma gangrenosum with myelofibrosis. Kanel, K.T., Kroboth, F.J., Swartz, W.M. Am. J. Med. (1987) [Pubmed]
  12. Aberrant integrin (CR4; alpha(x)beta2; CD11c/CD18) oscillations on neutrophils in a mild form of pyoderma gangrenosum. Shaya, S., Kindzelskii, A.L., Minor, J., Moore, E.C., Todd, R.F., Petty, H.R. J. Invest. Dermatol. (1998) [Pubmed]
  13. Clinical experience with clindamycin hydrochloride: I. Treatment of streptococcal and mixed streptococcal-staphylococcal skin infections. Dillon, H.C., Derrick, C.W. Pediatrics (1975) [Pubmed]
  14. Pyoderma gangrenosum complicating ulcerative colitis: successful treatment with methylprednisolone pulse therapy and dapsone. Galun, E., Flugelman, M.Y., Rachmilewitz, D. Am. J. Gastroenterol. (1986) [Pubmed]
  15. Isolation of Staphylococcus schleiferi from dogs with pyoderma. Frank, L.A., Kania, S.A., Hnilica, K.A., Wilkes, R.P., Bemis, D.A. J. Am. Vet. Med. Assoc. (2003) [Pubmed]
  16. Defective monocyte function in pyoderma gangrenosum with IgG kappa paraproteinaemia. Jones, R.R., Kobza Black, A., Donaghy, M., Moshtael, O., Pinching, A.J. Clin. Exp. Immunol. (1983) [Pubmed]
  17. Effect of trimethoprim/sulfamethoxazole on thyroid function in dogs with pyoderma. Hall, I.A., Campbell, K.L., Chambers, M.D., Davis, C.N. J. Am. Vet. Med. Assoc. (1993) [Pubmed]
  18. In vitro indices of tissue adherence in Staphylococcus intermedius. Cree, R.G., Noble, W.C. Lett. Appl. Microbiol. (1995) [Pubmed]
  19. Therapy Insight: pyoderma gangrenosum-old disease, new management. Campbell, S., Cripps, S., Jewell, D.P. Nature clinical practice. Gastroenterology & hepatology. (2005) [Pubmed]
  20. Treatment of recalcitrant ulcers in pyoderma gangrenosum with mycophenolate mofetil and autologous keratinocyte transplantation on a hyaluronic acid matrix. Wollina, U., Karamfilov, T. Journal of the European Academy of Dermatology and Venereology : JEADV. (2000) [Pubmed]
  21. Infevers: an evolving mutation database for auto-inflammatory syndromes. Touitou, I., Lesage, S., McDermott, M., Cuisset, L., Hoffman, H., Dode, C., Shoham, N., Aganna, E., Hugot, J.P., Wise, C., Waterham, H., Pugnere, D., Demaille, J., Sarrauste de Menthiere, C. Hum. Mutat. (2004) [Pubmed]
  22. A common pathway in periodic fever syndromes. McDermott, M.F. Trends Immunol. (2004) [Pubmed]
  23. Treatment of pyoderma gangrenosum with etanercept. McGowan, J.W., Johnson, C.A., Lynn, A. Journal of drugs in dermatology : JDD. (2004) [Pubmed]
  24. Pyoderma Gangrenosum and rheumatoid arthritis. Stolman, L.P., Rosenthal, D., Yaworsky, R., Horan, F. Archives of dermatology. (1975) [Pubmed]
  25. Fatal pyoderma gangrenosum in association with C7 deficiency. Friduss, S.R., Sadoff, W.I., Hern, A.E., Fivenson, D.P. J. Am. Acad. Dermatol. (1992) [Pubmed]
  26. Cutaneous infection due to Mycobacterium kansasii. Razavi, B., Cleveland, M.G. Diagn. Microbiol. Infect. Dis. (2000) [Pubmed]
  27. Minimizing the risk of post-operative pyoderma gangrenosum. Long, C.C., Jessop, J., Young, M., Holt, P.J. Br. J. Dermatol. (1992) [Pubmed]
  28. Pyoderma gangrenosum and cranial osteolysis: case report and review of the paediatric literature. Samlaska, C.P., Smith, R.A., Myers, J.B., Bottini, A.G., Person, D.A. Br. J. Dermatol. (1995) [Pubmed]
  29. Stabilization of pyoderma gangrenosum ulcer with oral cyclosporine prior to skin grafting. Zakhireh, M., Rockwell, W.B., Fryer, R.H. Plast. Reconstr. Surg. (2004) [Pubmed]
  30. Plasmapheresis and cyclophosphamide as successful treatments for pyoderma gangrenosum. Kaminska, R., Ikäheimo, R., Hollmen, A. Clin. Exp. Dermatol. (1999) [Pubmed]
WikiGenes - Universities